14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Wed, 8 May 2024

Trading levels for MTNB

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 0.184 7.84 %
R2 0.179 4.91 %
R1 0.176 3.10 %
Current price: 0.171
Support S1 0.166 -2.75 %
S2 0.163 -4.56 %
S3 0.158 -7.49 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0.209 22.22 %
R2 0.183 6.78 %
R1 0.182 6.14 %
Current price 0.171
Support S1 0.168 -1.75%
S2 0 .
S3 0 .

MTNB Predictions History

5 years ago
NameNotImportant predicted that MTNB for 2019-04-24 is going $1.01 (1.51%)

5 years ago
JS predicted that MTNB for 2019-04-22 is going $1.03 (0.00%)

5 years ago
Profit.Prophet.108044 predicted that MTNB for 2019-04-22 is going $1.05 (1.94%)

5 years ago
Profit.Prophet.108044 predicted that MTNB for 2019-04-17 is going $1.08 (4.85%)

5 years ago
JS predicted that MTNB for 2019-03-05 is going $1.24 (-8.82%)

5 years ago
Gp predicted that MTNB for 2019-03-05 is going $1.39 (2.21%)

5 years ago
PumpTheseNumbers predicted that MTNB for 2019-03-05 is going $1.41 (9.30%)

5 years ago
JS predicted that MTNB for 2019-01-30 is going $0.93 (-5.41%)

5 years ago
JS predicted that MTNB for 2019-01-24 is going $0.96 (-2.04%)

5 years ago
Jeff.Kinney.97458 predicted that MTNB for 2019-01-24 is going $0.87 (-11.12%)

Rank:
Click to get the best stock tips daily for free!

About Matinas Biopharma Holdings Inc

Matinas Biopharma Holdings Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of various product candidates. It develops products using its lipid nanocrystal (LNC) platform technology. The company's LNC delivery technology platform utilizes lipid nano-crystals for the delivery of small molecules, nucleic acids, gene therapies, vaccines, proteins, and peptides. Its lead product candidate is LYPDISO, a presc... MTNB Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT